Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison

Loke, Yoon K, Pradhan, Shiva, Yeong, Jessica Ka-Yan and Kwok, Chun Shing (2014) Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison. British Journal of Clinical Pharmacology, 78 (4). 707–717. ISSN 0306-5251

Full text not available from this repository. (Request a copy)

Abstract

There are concerns regarding increased risk of acute coronary syndrome with dabigatran. We aimed to assess whether alternative treatment options such as rivaroxaban or apixaban carry a similar risk as compared to dabigatran.

Item Type:	Article
Additional Information:	This article is protected by copyright. All rights reserved.
Uncontrolled Keywords:	acute coronary syndrome,apixaban,dabigatran
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Depositing User:	Pure Connector
Date Deposited:	07 Jul 2014 13:14
Last Modified:	06 Jun 2024 14:49
URI:	https://ueaeprints.uea.ac.uk/id/eprint/48919
DOI:	10.1111/bcp.12376

Actions (login required)

View Item